ClinicalTrials.gg
Status unknownNCT04151485Updated May 3, 2023

The Effect of the Mind/Body Program for Fertility, Hungarian Version, on Well-Being and Assisted Reproduction Outcomes

An interventional study of Mind/Body Program for Fertility (Domar et al., 2011) and Fertility Support Program in Infertility, Female, sponsored by Semmelweis University. Status unknown at 2 sites in Hungary. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2023-05-03.

Sponsored by Semmelweis University · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified May 2023), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
177
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

Involuntary childlessness is an emotionally stressful experience; however, psychosocial counseling is typically not available in Hungarian routine fertility care. The aim of this randomized controlled trial (RCT) is to examine the effectiveness of a Mind/Body psychological fertility intervention for women in reproductive treatment. We hypothesize that participants of the Mind/Body Program for Fertility, Hungarian version, will have more favorable psychological well-being, ART outcome results than participants of the Fertility Support Groups.

Read the detailed description

Involuntary childlessness imposes significant psychological burden on those affected, particularly those involved in assisted reproductive technology (ART). The reduction of psychological distress has been shown to improve the quality of life of those affected and to possibly increase chances of pregnancy. While in more developed countries psychological support is largely available in routine fertility care, it is not yet part of the Hungarian ART protocol.

In this study, the effects of a psychosocial intervention, namely, the Hungarian version of the Mind/Body Program for Fertility (Domar et al., 2011), will be tested on the psychological well-being and ART outcomes of women in reproductive treatment, in a randomized controlled pre-post design.

For this purpose, women in ART treatment will fill in screening questionnaires (on depression, anxiety, stress, etc.), and moderate to high scorers will be randomized into an intervention (Mind/Body) group (N=70) and a comparison intervention (Fertility Support) group (N=70), lasting for 10 weeks each, before and/or during an ART cycle. Both interventions will be delivered by the same clinical psychologist, listed as central contact person below, officially trained in the Mind/Body Program for Fertility by Dr. Alice Domar at Boston IVF, Waltham, Massachusetts. A smartphone application for rating subjective stress levels twice a day, from the start of the stimulation to the day of the pregnancy test, will also be administered. Additionally, whole-night sleep EEGs will be recorded.

Medical data (such as diagnosis, hormone levels, previous treatment cycles, etc.) and sociodemographic (such as age, education, etc.) and psychological variables (such as personality traits, chronotype, intelligence, etc.) as potential moderators, as well as ART outcomes will be reported. Data of respondents willing to fill in pre- and post-questionnaires but 1) not motivated to take part in the study, or 2) motivated to take part in the study, but not able to make it, will be registered but excluded from statistical analysis comparing RCT results.

02

Conditions studied

  • Infertility, Female

Keywords

  • female infertility
  • assisted reproductive technology
  • in vitro fertilization
  • intra-cytoplasmic sperm injection
  • pregnancy
  • stress
  • depression
  • anxiety
  • quality of life
  • sleep quality
  • circadian rhythm
  • mind/body
03

In context

Infertility, Female

553 studies on the registry are indexed under Infertility, Female; 136 are open to participants now.

This study's enrollment of 177 is above the median of 100 across 377 interventional studies indexed under Infertility, Female.

Browse Infertility, Female studies →

Lead sponsor

Semmelweis University is the lead sponsor of 139 studies on the registry; 55 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria: All women awaiting or undergoing infertility treatment (insemination, in vitro fertilization or intracytoplasmic sperm injection) at the Assisted Reproduction Center of the Department of Obstetrics and Gynecology at Semmelweis University, Budapest, who:

  • give informed consent to participating in the study
  • have sufficient knowledge of the Hungarian language

Exclusion Criteria:

  • active psychotic episode
  • severe depression or other major psychiatric diagnoses
  • substance abuse
  • eating disorders
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
177 participants (actual)

Study arms

  • Experimental
    Mind/Body Group

    All persons allocated to the intervention group will take part in a 10-week Mind/Body skills development fertility program parallel with fertility workup and treatment.

    Behavioral: Mind/Body Program for Fertility (Domar et al., 2011)

  • Active comparator
    Support Group

    All persons allocated to the comparison intervention group will take part in a 10-week fertility support program parallel with fertility workup and treatment.

    Behavioral: Fertility Support Program

Interventions

  • BehavioralMind/Body Program for Fertility (Domar et al., 2011)

    see Arm Description

  • BehavioralFertility Support Program

    see Arm Description

06

What researchers measure

Primary outcomes

  1. Mean change from baseline in results on the Fertility Quality of Life tool

    Mean change from baseline in results on the Fertility Quality of Life (FertiQoL) Core Scale, subscales and Treatment Module

    Time frame: through study completion, an average of 2 years

  2. Mean change from baseline in results on the SCREENIVF tool

    Mean change from baseline in results on the SCREENIVF tool and its subscales

    Time frame: through study completion, an average of 2 years

  3. Clinical pregnancy

    Rate of clinical pregnancies at post-measurement

    Time frame: through study completion, an average of 2 years

Secondary outcomes

  1. Mean change from baseline on a Likert scale measuring strength of intention to continue treatment

    Mean change from baseline on a 10-point Likert scale measuring strength of intention to continue treatment (if first ART cycle not successful) to post-measurement

    Time frame: through study completion, an average of 2 years

Other outcomes

  1. Mean change from baseline in results on the Beck Depression Inventory

    Mean change from baseline in results on the 21-item Beck Depression Inventory (BDI), with special attention to category change (e.g. from moderate to mild depression level, from mild to no depression)

    Time frame: through study completion, an average of 2 years

  2. Mean change from baseline in results on the World Health Organisation-Five Well-Being Index

    Mean change from baseline in results on the 5-item World Health Organisation-Five Well-Being Index (WHO-5)

    Time frame: through study completion, an average of 2 years

  3. Mean change from baseline in results on the Spielberger State-Trait Anxiety Inventory

    Mean change from baseline in results on the State and Trait subscales of the Spielberger State Trait Anxiety Inventory (STAI)

    Time frame: through study completion, an average of 2 years

  4. Mean change from baseline in results on the Short Stress Scale

    Mean change from baseline in results on the 26-item Short Stress Scale (SSS)

    Time frame: through study completion, an average of 2 years

  5. Mean change from baseline in results on the Perceived Stress Scale

    Mean change from baseline in results on the 10-item Perceived Stress Scale (PSS-10)

    Time frame: through study completion, an average of 2 years

  6. Mean change from baseline in results on the Life Meaning subscale of the Brief Stress and Coping Inventory

    Mean change from baseline in results on the 7-item Life Meaning subscale of the Brief Stress and Coping Inventory (BSCI-LM)

    Time frame: through study completion, an average of 2 years

  7. Mean change from baseline in results on the Awareness of Mind-Body Integration and the Trusting Body Sensations subscales of the Multidimensional Assessment of Interoceptive Awareness

    Mean change from baseline in results on the 12-item Awareness of Mind-Body Integration and the 3-item Trusting Body Sensations subscales of the Multidimensional Assessment of Interoceptive Awareness (MAIA)

    Time frame: through study completion, an average of 2 years

  8. Mean change from baseline in results on the Fertility Problem Stress Scales and the Coping Strategy Scales of the Copenhagen Multi-centre Psychosocial Infertility study questionnaire

    Mean change from baseline in results on the 14-item Fertility Problem Stress Scales and the 19-item Coping Strategy Scales of the Copenhagen Multi-centre Psychosocial Infertility (COMPI) study questionnaire

    Time frame: through study completion, an average of 2 years

  9. Mean change from baseline in results on the Sexual Concerns subscale of the Fertility Problem Inventory

    Mean change from baseline in results on the 8-item Sexual Concerns subscale of the Fertility Problem Inventory

    Time frame: through study completion, an average of 2 years

  10. Mean change from baseline in results on the Relationship Assessment Scale

    Mean change from baseline in results on the 7-item Relationship Assessment Scale (RAS)

    Time frame: through study completion, an average of 2 years

  11. Mean change from baseline in results on the Pittsburgh Sleep Quality Index

    Mean change from baseline in results on the Pittsburgh Sleep Quality Index (PSQI)

    Time frame: through study completion, an average of 2 years

  12. Mean change from baseline in results on the Athens Insomnia Scale

    Mean change from baseline in results on the 8-item Athens Insomnia Scale (AIS)

    Time frame: through study completion, an average of 2 years

  13. Mean results on a smartphone-based Likert-scale rating momentary stress

    Mean results on the StressFlash smartphone-based Likert-scale rating momentary stress

    Time frame: through study completion, an average of 2 years

  14. Number of oocytes retrieved

    Number of oocytes retrieved at transvaginal oocyte retrieval (TVOR)

    Time frame: through study completion, an average of 2 years

  15. Number of oocytes fertilized

    Number of oocytes fertilized via IVF/ICSI

    Time frame: through study completion, an average of 2 years

  16. Number of embryos transferred

    Number of embryos transferred at embryo transfer (ET)

    Time frame: through study completion, an average of 2 years

07

Study locations

2 sites
  • Assisted Reproduction Center of the Department of Obstetrics and Gynecology at Semmelweis University
    Budapest, 1082, Hungary
  • Institute of Behavioral Sciences at Semmelweis University
    Budapest, 1089, Hungary
08

References and documents

Publications

  • Domar AD, Rooney KL, Wiegand B, Orav EJ, Alper MM, Berger BM, Nikolovski J. Impact of a group mind/body intervention on pregnancy rates in IVF patients. Fertil Steril. 2011 Jun;95(7):2269-73. doi: 10.1016/j.fertnstert.2011.03.046. Epub 2011 Apr 15. PubMed 21496800 ↗
  • Szigeti F J, Kazinczi C, Szabo G, Sipos M, Ujma PP, Purebl G. The clinical effectiveness of the Mind/Body Program for Infertility on wellbeing and assisted reproduction outcomes: a randomized controlled trial in search for active ingredients. Hum Reprod. 2024 Aug 1;39(8):1735-1751. doi: 10.1093/humrep/deae119. PubMed 38852061 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2019 (actual). Primary completion is estimated for Jul 2023, 43 months after the start.

Of 139 non-industry interventional studies with no phase under Infertility, Female, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's planned 43 months is above that.

Counting every sponsor, half of 152 studies reached it within 23 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 28, 2019
First posted
Nov 5, 2019
StartActual
Dec 15, 2019
Primary completionEst.
Jul 2023
CompletionEst.
Aug 2023
Last update
May 3, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 3, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04151485
Responsible party
Sponsor
First posted
Nov 5, 2019
Start date
Dec 15, 2019
Primary completion
Jul 2023 (estimated)
Completion
Aug 2023 (estimated)
Last update
May 3, 2023

Study contacts

György Purebl, PhD Ass.Prof
principal investigator · Institute of Behavioural Sciences, Semmelweis University, Budapest

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion